1. Is the Standard implemented in your Office's/Organization's practice? (Please choose one of the options below)
- Completely
- Partly
- Not Implemented
2. If the answer was "Partly", please explain your Office's/Organization's practice briefly:
3. If the answer was "Not Implemented", does your Office/Organization plan to implement the Standard?
4. Comments (optional)
IPO currently examines biological sequence listings using the authoring tool CRF4 which was developed by the USPTO and is ST.25 compliant.
CIPO plans to upgrade to ST.26 for nucleotide and amino acid sequence listing when the replacement authoring tool becomes available.
1. Is the Standard implemented in your Office's/Organization's practice? (Please choose one of the options below)
- Completely
- Partly
- Not Implemented
2. If the answer was "Partly", please explain your Office's/Organization's practice briefly:
SIPO has our own standard which refers to ST.25, but it is not mandatory for the applicants to submit the sequence listings according to the standard in our practice.
3. If the answer was "Not Implemented", does your Office/Organization plan to implement the Standard?
4. Comments (optional)
1. Is the Standard implemented in your Office's/Organization's practice? (Please choose one of the options below)
- Completely
- Partly
- Not Implemented
2. If the answer was "Partly", please explain your Office's/Organization's practice briefly:
Only principal recommendations
3. If the answer was "Not Implemented", does your Office/Organization plan to implement the Standard?
4. Comments (optional)
1. Is the Standard implemented in your Office's/Organization's practice? (Please choose one of the options below)
- Completely
- Partly
- Not Implemented
2. If the answer was "Partly", please explain your Office's/Organization's practice briefly:
3. If the answer was "Not Implemented", does your Office/Organization plan to implement the Standard?
4. Comments (optional)
1. Is the Standard implemented in your Office's/Organization's practice? (Please choose one of the options below)
- Completely
- Partly
- Not Implemented
2. If the answer was "Partly", please explain your Office's/Organization's practice briefly:
3. If the answer was "Not Implemented", does your Office/Organization plan to implement the Standard?
4. Comments (optional)
1. ¿Se aplica la norma en la práctica de su Oficina/Organización? (Por favor seleccione una de las opciones)
- Completamente
- Parcialmente
- No se aplica
2. Si la respuesta es “Parcialmente”, explique brevemente la práctica de su Oficina/Organización.
3. Si la respuesta es “No se aplica”, ¿tiene previsto su Oficina/Organización aplicar la norma?
4. Commentarios (facultativo)
Las listas de secuencias son especialmente presentadas de conformidad a las normas del PCT. El instituto utiliza regularmente el sistema EPCT para la transferencia de los documentos completos y las listas de secuencias de nucleótidos y aminoácidos apegándose a los requerimientos establecidos bajo esa plataforma. Sin embargo, también se tiene la práctica de enviar los listados de secuencia en formato papel como parte integral de la documentación Técnica a las Oficinas Internacionales de búsqueda.
1. Is the Standard implemented in your Office's/Organization's practice? (Please choose one of the options below)
- Completely
- Partly
- Not Implemented
2. If the answer was "Partly", please explain your Office's/Organization's practice briefly:
3. If the answer was "Not Implemented", does your Office/Organization plan to implement the Standard?
PLANNING TO IMPLEMENT in the future
4. Comments (optional)
1. Is the Standard implemented in your Office's/Organization's practice? (Please choose one of the options below)
- Completely
- Partly
- Not Implemented
2. If the answer was "Partly", please explain your Office's/Organization's practice briefly:
3. If the answer was "Not Implemented", does your Office/Organization plan to implement the Standard?
4. Comments (optional)